ADORA3 and Cognitive impairment: ADORA3 antagonist promotes the expression of Mertk and Axl in microglia by facilitating cAMP/PKA/p‐CREB pathway, enhances microglial phagocytosis to myelin debris, and improves white matter injury and cognitive impairment in BCAS mice.